Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Suomen OEL Oy
OY
Active
Y-tunnus 0649381-1
Sinikalliontie 3C, 02630
Espoo
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1986
— employees
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Suomen OEL Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
1M
1M
2M
2M
1M
2020
2M
2022
2M
2023
2M
2024
1M
2025
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2020
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
EUR thousands
Item
2020
2022
2023
2024
2025
Revenue
1 080
2 410
1 565
1 604
1 420
Staff expenses
−201
−295
−239
−201
−226
EBITDA
24
346
53
20
13
Depreciation & amort.
−6
−39
−10
−7
−6
EBIT
18
307
43
13
8
Net financials
—
0
0
2
3
Profit before tax
18
307
43
15
11
Tax
4
62
9
4
2
Net profit
13
245
35
11
9
Balance sheet
EUR thousands
Item
2020
2022
2023
2024
2025
Total assets
398
699
847
819
624
Equity
335
580
460
471
469
Long-term debt
—
—
0
0
0
Short-term debt
63
119
387
348
155
Total debt
63
119
387
348
155
Financial ratios
5-year trend
EBITDA margin
0.9%
This company
15.8%
Market median
-94% vs market
2020
2025
Equity ratio
75.1%
This company
38.2%
Market median
+97% vs market
2020
2025
Return on equity
1.9%
This company
18.4%
Market median
-90% vs market
2020
2025
Net profit margin
0.6%
This company
8.1%
Market median
-93% vs market
2020
2025
Asset turnover
2.27×
This company
1.12×
Market median
+103% vs market
2020
2025
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
2020
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-01-01 – 2022-06-30
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
More on Suomen OEL Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
